OPRX is trading 5.1% up at $5.38 after bullish analyst commentary and an AI product launch reignited interest in the stock.
- Citizens recently reiterated its Market Outperform rating and $9 price target, signaling significant growth potential.
- OptimizeRx introduced a new AI-powered tool for pharma marketers designed to enhance engagement and drive revenue.
- Investor sentiment is improving as the company capitalizes on AI integration amid a broadly rising market.